HELP ▲ +14.2% - Cybin D/B/A Helus Pharma
$HELP - Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
Helus Pharma rose 14.2% today following news that the company will participate in the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit. Conference participation announcements typically generate investor interest by providing a platform for the company to present its neuropsychiatry pipeline and research progress to institutional investors and industry professionals.
21-SEP-2026 05:15 PM ET
Share this post
More filings for $HELP
HELP ▲ +2.8% - Cybin D/B/A Helus PharmaSep 21, 2026HELP ▲ +1.3% - Cybin D/B/A Helus PharmaSep 10, 2026HELP - Cybin D/B/A Helus Pharma - SEC Filing Update (09-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 9, 2026HELP - Cybin D/B/A Helus Pharma - SEC Filing Update (09-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 9, 2026HELP ▲ +3.2% - Cybin D/B/A Helus PharmaSep 9, 2026HELP ▲ +1.1% - Cybin D/B/A Helus PharmaSep 3, 2026
View full $HELP filing history →💬 Comments
Loading comments…
Leave a comment
